Eko Appoints Bryan Humbarger to the Position of Senior Vice President, Commercial

My account

Cart

Checkout

Bryan Humbarger has been appointed to the position of Senior Vice President, Eko Commercial. In this role, Mr. Humbarger will oversee sales and commercial operations for Eko’s AI and telemedicine software platforms for health systems, practices and providers worldwide.

Mr. Humbarger most recently served as Vice President of Sales at cardiac digital health companies AliveCor and Heartflow. Previously, he spent nearly two decades gaining sales experience at medical device and technology companies, including Medtronic and Bioquell.

“Bryan’s leadership skills, proven ability to drive growth and passion for improving cardiac health will be key assets as Eko continues to expand adoption of our AI and telemedicine solutions,” said Connor Landgraf, CEO and co-founder of Eko. “Now more than ever, telemedicine is playing a critical role in caring for patients and Bryan will play a pivotal part in scaling operations for the company’s next phase of growth and continued expansion.”

Mr. Humbarger joins Eko following the achievement of several key company milestones, including the clearance of its cardiac AI algorithms by the U.S. Food and Drug Administration and the launch of Eko’s AI-powered telehealth platform.

“Eko’s next generation of cardiac and pulmonary solutions are already making a difference for providers and their patients, and I am thrilled to bring my experience in cardiology and digital health to further accelerate the adoption of Eko’s technology,” said Mr. Humbarger. “Being at the forefront of delivering what’s next in cardiovascular care is my passion, and I am thrilled to continue this journey at Eko, a company making a difference in how cardiac and pulmonary care is delivered.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.